1	IL-2	il-2	_	_	_	_	_	_	_
2	gene	gene	_	_	_	_	_	_	_
3	expression	expression	_	_	_	_	_	_	_
4	and	and	_	_	_	_	_	_	_
5	NF-kappa	NF-kappa	_	_	_	_	_	_	_
6	B	B	_	_	_	_	_	_	_
7	activation	activation	_	_	_	_	_	_	_
8	through	through	_	_	_	_	_	_	_
9	CD28	cd28	_	_	_	_	_	_	_
10	requires	require	_	_	_	_	_	_	_
11	reactive	reactive	_	_	_	_	_	_	_
12	oxygen	oxygen	_	_	_	_	_	_	_
13	production	production	_	_	_	_	_	_	_
14	by	by	_	_	_	_	_	_	_
15	5-lipoxygenase	5-lipoxygenase	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	Activation	Activation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	CD28	cd28	_	_	_	_	_	_	_
5	surface	surface	_	_	_	_	_	_	_
6	receptor	receptor	_	_	_	_	_	_	_
7	provides	provide	_	_	_	_	_	_	_
8	a	a	_	_	_	_	_	_	_
9	major	major	_	_	_	_	_	_	_
10	costimulatory	costimulatory	_	_	_	_	_	_	_
11	signal	signal	_	_	_	_	_	_	_
12	for	for	_	_	_	_	_	_	_
13	T	t	_	_	_	_	_	_	_
14	cell	cell	_	_	_	_	_	_	_
15	activation	activation	_	_	_	_	_	_	_
16	resulting	result	_	_	_	_	_	_	_
17	in	in	_	_	_	_	_	_	_
18	enhanced	enhance	_	_	_	_	_	_	_
19	production	production	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	interleukin-2	interleukin-2	_	_	_	_	_	_	_
22	(	(	_	_	_	_	_	_	_
23	IL-2	il-2	_	_	_	_	_	_	_
24	)	)	_	_	_	_	_	_	_
25	and	and	_	_	_	_	_	_	_
26	cell	cell	_	_	_	_	_	_	_
27	proliferation	proliferation	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	In	in	_	_	_	_	_	_	_
2	primary	primary	_	_	_	_	_	_	_
3	T	t	_	_	_	_	_	_	_
4	lymphocytes	lymphocyte	_	_	_	_	_	_	_
5	we	we	_	_	_	_	_	_	_
6	show	show	_	_	_	_	_	_	_
7	that	that	_	_	_	_	_	_	_
8	CD28	cd28	_	_	_	_	_	_	_
9	ligation	ligation	_	_	_	_	_	_	_
10	leads	lead	_	_	_	_	_	_	_
11	to	to	_	_	_	_	_	_	_
12	the	the	_	_	_	_	_	_	_
13	rapid	rapid	_	_	_	_	_	_	_
14	intracellular	intracellular	_	_	_	_	_	_	_
15	formation	formation	_	_	_	_	_	_	_
16	of	of	_	_	_	_	_	_	_
17	reactive	reactive	_	_	_	_	_	_	_
18	oxygen	oxygen	_	_	_	_	_	_	_
19	intermediates	intermediate	_	_	_	_	_	_	_
20	(	(	_	_	_	_	_	_	_
21	ROIs	ROI	_	_	_	_	_	_	_
22	)	)	_	_	_	_	_	_	_
23	which	which	_	_	_	_	_	_	_
24	are	be	_	_	_	_	_	_	_
25	required	require	_	_	_	_	_	_	_
26	for	for	_	_	_	_	_	_	_
27	CD28-mediated	cd28-mediated	_	_	_	_	_	_	_
28	activation	activation	_	_	_	_	_	_	_
29	of	of	_	_	_	_	_	_	_
30	the	the	_	_	_	_	_	_	_
31	NF-kappa	NF-kappa	_	_	_	_	_	_	_
32	B/CD28-responsive	b/cd28-responsive	_	_	_	_	_	_	_
33	complex	complex	_	_	_	_	_	_	_
34	and	and	_	_	_	_	_	_	_
35	IL-2	il-2	_	_	_	_	_	_	_
36	expression	expression	_	_	_	_	_	_	_
37	.	.	_	_	_	_	_	_	_

1	Delineation	Delineation	_	_	_	_	_	_	_
2	of	of	_	_	_	_	_	_	_
3	the	the	_	_	_	_	_	_	_
4	CD28	cd28	_	_	_	_	_	_	_
5	signaling	signaling	_	_	_	_	_	_	_
6	cascade	cascade	_	_	_	_	_	_	_
7	was	be	_	_	_	_	_	_	_
8	found	find	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	involve	involve	_	_	_	_	_	_	_
11	protein	protein	_	_	_	_	_	_	_
12	tyrosine	tyrosine	_	_	_	_	_	_	_
13	kinase	kinase	_	_	_	_	_	_	_
14	activity	activity	_	_	_	_	_	_	_
15	,	,	_	_	_	_	_	_	_
16	followed	follow	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	the	the	_	_	_	_	_	_	_
19	activation	activation	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	phospholipase	phospholipase	_	_	_	_	_	_	_
22	A2	a2	_	_	_	_	_	_	_
23	and	and	_	_	_	_	_	_	_
24	5-lipoxygenase	5-lipoxygenase	_	_	_	_	_	_	_
25	.	.	_	_	_	_	_	_	_

1	Our	our	_	_	_	_	_	_	_
2	data	datum	_	_	_	_	_	_	_
3	suggest	suggest	_	_	_	_	_	_	_
4	that	that	_	_	_	_	_	_	_
5	lipoxygenase	lipoxygenase	_	_	_	_	_	_	_
6	metabolites	metabolite	_	_	_	_	_	_	_
7	activate	activate	_	_	_	_	_	_	_
8	ROI	ROI	_	_	_	_	_	_	_
9	formation	formation	_	_	_	_	_	_	_
10	which	which	_	_	_	_	_	_	_
11	then	then	_	_	_	_	_	_	_
12	induce	induce	_	_	_	_	_	_	_
13	IL-2	il-2	_	_	_	_	_	_	_
14	expression	expression	_	_	_	_	_	_	_
15	via	via	_	_	_	_	_	_	_
16	NF-kappa	NF-kappa	_	_	_	_	_	_	_
17	B	B	_	_	_	_	_	_	_
18	activation	activation	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	These	these	_	_	_	_	_	_	_
2	findings	finding	_	_	_	_	_	_	_
3	should	should	_	_	_	_	_	_	_
4	be	be	_	_	_	_	_	_	_
5	useful	useful	_	_	_	_	_	_	_
6	for	for	_	_	_	_	_	_	_
7	therapeutic	therapeutic	_	_	_	_	_	_	_
8	strategies	strategy	_	_	_	_	_	_	_
9	and	and	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	development	development	_	_	_	_	_	_	_
12	of	of	_	_	_	_	_	_	_
13	immunosuppressants	immunosuppressant	_	_	_	_	_	_	_
14	targeting	target	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	CD28	cd28	_	_	_	_	_	_	_
17	costimulatory	costimulatory	_	_	_	_	_	_	_
18	pathway	pathway	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

